review · Foods
Pleurotus ostreatus contains bioactive substances across its mycelium, fruiting body, and spent substrate that display both prebiotic and antimicrobial properties. Non-digestible carbohydrates such as chitin and glucan function as prebiotics, promoting the growth and activity of beneficial gut bacteria to help maintain a balanced microbiome. Alongside these polysaccharides, secondary metabolites including phenolic compounds, terpenoids, and lectins exhibit antibacterial, antiviral, and antifungal capabilities. When consumed, these components inhibit harmful microorganisms in the digestive tract, potentially reducing infection rates and lowering the risk of antibiotic resistance. While incorporating mushroom-derived foods into diets can support digestive wellness and lessen reliance on conventional antibiotics, additional research remains necessary to evaluate effectiveness against specific pathogens and completely map these biological activities.
Maintaining a balanced gut microbiome is vital for human digestion and overall health. As concerns over antibiotic resistance grow worldwide, dietary sources that naturally discourage harmful microbes and foster beneficial bacteria provide valuable preventive options. Using edible mushrooms to strengthen gut health could offer accessible dietary strategies to support immune defence and reduce dependence on traditional antibiotic therapies.
The findings suggest potential applications in functional foods, dietary supplements, and nutraceutical formulations aimed at digestive health. Product developers and food manufacturers utilising mushroom biomass or spent substrate could potentially draw on these ingredients. However, the work remains at an early research stage, as the abstract notes that further studies are necessary to prove efficacy against particular pathogens and verify its properties before clinical or commercial development can proceed.
AI-generated from the published abstract. Always read the original work before citing.
<i>Pleurotus ostreatus</i> (Jacq. ex Fr.) P. Kumm mushroom contains bioactive compounds with both antimicrobial and prebiotic properties, which are distributed in the mushroom mycelium, fruiting body, and spent substrate. The mushroom is rich in nondigestible carbohydrates like chitin and glucan, which act as prebiotics and support the growth and activity of beneficial gut bacteria, thereby maintaining a healthy balance of gut microbiota and reducing the risk of antibiotic resistance. The bioactive compounds in <i>P. ostreatus</i> mushrooms, including polysaccharides (glucans, chitin) and secondary metabolites (phenolic compounds, terpenoids, and lectins), exhibit antibacterial, antiviral, and antifungal activities. When mushrooms are consumed, these compounds can help preventing the growth and spread of harmful bacteria in the gut, reducing the risk of infections and the development of antibiotic resistance. Nonetheless, further research is necessary to determine the efficacy of <i>P. ostreatus</i> against different pathogens and to fully comprehend its prebiotic and antimicrobial properties. Overall, consuming a diet rich in mushroom-based foods can have a positive impact on human digestion health. A mushroom-based diet can support a healthy gut microbiome and reduce the need for antibiotics.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.3390/foods12102010
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.
